Percutaneous Mechanical Circulatory Support Devices Market projected to reach US$3,964.75 million by 2027 - Eurosets, Berlin Heart, CardioBridge, Jarvik Heart

Percutaneous mechanical circulatory support devices offers an effective and rapid approach to slow the downward spiral of hemodynamic instability among patients suffering with decompensated heart failures and cardiogenic shocks till a more definitive strategy is perceived among patients to recover from these cardiac ailments. The major roles of the percutaneous mechanical circulatory support devices include improving the native cardiac output, reducing ventricular volume and filling pressures, augmenting coronary perfusion, and maintaining vital organ perfusion.

The percutaneous mechanical circulatory support devices market was valued at US$1,474.28 million in 2019 and is projected to reach US$3,964.75 millionby2027; it is expected to grow at a CAGR of 13.5% during2020–2027.

Get Sample Report of percutaneous mechanical circulatory support devices market Report @ https://www.theinsightpartners.com/sample/TIPRE00003194/?openpr-10144

Abbott, Medtronic, Getinge AB, Teleflex Incorporated, Livanova Plc (Cardiacassist, Inc.), Abiomed, Eurosets, Berlin Heart, Jarvik Heart, Inc., and CardioBridge GmbH and Company are among the leading companies operating in the percutaneous mechanical circulatory support devices market.

The companies are focused toward the adoption of organic strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in June 2016, Medetronic launched a product—Beacon, a care management service for high-risk heart failure patients. This service combines data from Medtronic implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT) devices with post-acute monitoring from MCMS.

The high market growth is anticipated on account of the rising global geriatric population. In both male and female population, the risk of cardiovascular diseases increases with an increase in age. Aging blood vessels are less flexible, leading to reduced blood flow. Thus, the risk of heart disease is high in the elderly population. Also, according to the Heart Disease and Stroke Statistics 2018, the average age at the first heart attack is 65.6 years for males and 72.0 years for females. It also mentioned that the annual incidence of a heart attack in the US is 720,000 new attacks and 335,000 recurrent attacks.

Moreover, according to the National Institutes of Health (NIH), America’s 65-and-over population is projected to nearly double over the next three decades, from 48 million to 88 million by 2050. Cardiovascular disease (CVD) in older Americans imposes a huge burden in terms of mortality, morbidity, disability, functional decline, and healthcare costs. A retrospective study performed by the University of Pittsburgh in 2015 states that the prevalence of CVD, including hypertension, CHD, HF, and stroke, increases from about 40% in men and women 40–59 years and 70-75% in persons aged 60–79 years, and 79–86% among those aged 80 years or older. Thus, the growing geriatric population leading to higher risks of heart failures and cardiogenic shocks increases the applications of percutaneous mechanical circulatory support devices and eventually favors market growth.

The product segment of the percutaneous mechanical circulatory support devices market is segmented into intra-aortic balloon pumps, VA-extracorporeal membrane oxygenation, and short-term ventricular assist devices. The intra-aortic balloon pumps segment held the largest share of the percutaneous mechanical circulatory support devices market in 2019. The short-term ventricular assist devices segment is anticipated to grow at aCAGR of 14.0% during the forecast period.

The end user segment of the percutaneous mechanical circulatory support devices market is segmented hospitals, ambulatory surgical centers, and others. The hospitals segment heldthe largest shareof the percutaneous mechanical circulatory support devices market in 2019. The segment is also anticipated to grow at a CAGR of 14.2% during the forecast period.

Interested in purchasing this Report? Click here @ https://www.theinsightpartners.com/buy/TIPRE00003194/?openpr-10144

Reason To Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the percutaneous mechanical circulatory support devices market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global percutaneous mechanical circulatory support devices market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact US:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.